$ANNX 4 SEC Filings

Filed On	Filing
25 Sep 2026	Form 4: Love Douglas, Director Bought 26,065 shares ($99.8K)
12 Aug 2026	Form 4: Blumenkranz Mark S., Director Granted 175,000 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Waddill William D., Director Granted 65,000 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Satter Muneer A, Director Granted 65,000 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Jones William A Jr, Director Granted 65,000 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Cockroft Bettina M., Director Granted 65,000 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Choi Jung, Director Granted 65,000 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Carson William H., Director Granted 65,000 Stock Option (Right to Buy)
15 Jun 2026	Form 4: Yednock Ted, EVP & CHIEF INNOVATION OFFICER Received 30,646 shares by exercise or conversion ($56.7K)
29 May 2026	Form 4: Satter Muneer A, Director Bought 613,497 shares ($3.32M)
13 May 2026	Form 4: Carson William H., Director Bought 8,000 shares ($46.2K)
14 Apr 2026	Form 4: Carson William H., Director Bought 8,000 shares ($49.6K)
12 Mar 2026	Form 4: Carson William H., Director Bought 8,000 shares ($45.4K)
04 Mar 2026	Form 4: Dananberg Jamie, CHIEF MEDICAL OFFICER Sold 5,820 shares ($31.6K)
04 Mar 2026	Form 4: Overdorf Michael, EVP & CHIEF BUSINESS OFFICER Sold 4,339 shares ($23.5K)
04 Mar 2026	Form 4: Yednock Ted, EVP & CHIEF INNOVATION OFFICER Sold 5,566 shares ($30.2K)
04 Mar 2026	Form 4: Artis Dean Richard, EVP & CHIEF SCIENTIFIC OFFICER Sold 5,894 shares ($32K)
04 Mar 2026	Form 4: Lew Jennifer, EVP & CHIEF FINANCIAL OFFICER Sold 5,565 shares ($30.2K)
23 Feb 2026	Form 4: Love Douglas, Director Granted 1,250,000 Stock Option (Right to Buy)
23 Feb 2026	Form 4: Dananberg Jamie, CHIEF MEDICAL OFFICER Received 56,250 shares as a grant or award · Granted 225,000 Stock Option (Right to Buy)

Comments